June 30, 2025
Condensed Interim Statement of Financial Position
(Unaudited)
(In thousands of Canadian dollars) |
June 30, 2025 |
March 31, 2025 |
Assets |
|
|
Current assets |
|
|
Cash |
$ 21,740 |
$ 102,215 |
Trade and other receivables (note 4) |
142,431 |
80,371 |
Inventories |
17,724 |
18,776 |
Prepaids |
8,063 |
8,603 |
Derivative financial assets |
12 |
855 |
|
189,970 |
210,820 |
Non-current assets |
|
|
Property and equipment (note 5) |
385,120 |
382,154 |
Intangible assets (note 6) |
12,290 |
12,879 |
Right-of-use assets (note 7) |
15,899 |
16,664 |
Employee benefits asset (note 8) |
73,523 |
64,809 |
Derivative financial assets |
- |
59 |
|
486,832 |
476,565 |
Total assets |
$ 676,802 |
$ 687,385 |
Liabilities and Equity |
|
|
Current liabilities |
|
|
Trade and other payables |
$ 167,252 |
$ 182,949 |
Holdbacks |
35 |
35 |
Lease liabilities (note 7) |
3,371 |
3,263 |
Deferred government funding related to operating expenses (note 10) |
25,787 |
27,379 |
Derivative financial liabilities |
637 |
58 |
|
197,082 |
213,684 |
Non-current liabilities |
|
|
Lease liabilities (note 7) |
14,882 |
15,738 |
Deferred government funding related to capital expenditures (note 10) |
392,089 |
389,690 |
Employee benefits liability (note 8) |
22,374 |
22,445 |
Deferred revenue - screening services - other |
4,571 |
4,571 |
|
433,916 |
432,444 |
Equity |
|
|
Accumulated surplus |
45,804 |
41,257 |
Total liabilities and equity |
$ 676,802 |
$ 687,385 |
Contingencies (note 9) and contractual arrangements (note 13)
The accompanying notes are an integral part of these condensed interim financial statements.
Condensed Interim Statement of Comprehensive Income (Loss)
(Unaudited)
(In thousands of Canadian dollars) |
Three Months Ended June 30 |
|
2025 |
2024 |
Expenses |
|
|
Pre-Board Screening |
$ 175,060 |
$ 157,222 |
Hold Baggage Screening |
46,250 |
40,983 |
Non-Passenger Screening |
41,103 |
36,855 |
Restricted Area Identity Card Program |
1,067 |
1,060 |
Corporate services |
15,032 |
13,519 |
Total expenses (note 11) |
278,512 |
249,639 |
Other expenses |
|
|
Net loss (gain) on fair value of derivative financial instruments |
1,481 |
(147) |
Finance costs |
169 |
177 |
Foreign exchange gain |
(219) |
(9) |
Total other expenses |
1,431 |
21 |
Financial performance before revenue and government funding |
279,943 |
249,660 |
Revenue |
|
|
Finance income |
735 |
902 |
Miscellaneous income |
18 |
2 |
Total revenue |
753 |
904 |
Government funding |
|
|
Parliamentary appropriations for operating expenses |
259,858 |
234,645 |
Amortization of deferred government funding related to capital expenditures |
13,008 |
11,041 |
Parliamentary appropriations for lease payments |
978 |
777 |
Total government funding (note 10) |
273,844 |
246,463 |
Financial performance |
$ (5,346) |
$ (2,293) |
Other comprehensive income |
|
|
Item that will not be reclassified to financial performance |
|
|
Remeasurement of defined benefit plans (note 8) |
9,893 |
4,130 |
Total comprehensive income (loss) |
$ 4,547 |
$ 1,837 |
The accompanying notes are an integral part of these condensed interim financial statements.
Condensed Interim Statement of Changes in Equity
(Unaudited)
For the three months ended June 30:
(In thousands of Canadian dollars) |
Accumulated surplus |
Balance, March 31, 2025 |
$ 41,257 |
Financial performance |
(5,346) |
Item that will not be reclassified to financial performance |
|
Remeasurement of defined benefit plans (note 8) |
9,893 |
Balance, June 30, 2025 |
$ 45,804 |
Balance, March 31, 2024 |
$ 36,901 |
Financial performance |
(2,293) |
Item that will not be reclassified to financial performance |
|
Remeasurement of defined benefit plans (note 8) |
4,130 |
Balance, June 30, 2024 |
$ 38,738 |
Condensed Interim Statement of Cash Flows
(Unaudited)
(In thousands of Canadian dollars) |
Three Months Ended June 30 |
|
2025 |
2024 |
Cash flows provided by (used in) |
|
|
Operating activities |
|
|
Financial performance |
$ (5,346) |
$ (2,293) |
Items not involving cash |
|
|
Depreciation and amortization (note 11) |
13,870 |
11,731 |
Change in fair value of financial instruments at fair value through profit and loss |
1,481 |
(147) |
Change in net employee benefits asset/liability |
1,108 |
2 |
Amortization of deferred government funding related to capital expenditures (note 10) |
(13,008) |
(11,041) |
Net change in working capital balances (note 15) |
(79,549) |
6,513 |
|
(81,444) |
4,765 |
Investing activities |
|
|
Parliamentary appropriations received for capital funding (note 10) |
15,022 |
4,223 |
Purchase of property and equipment |
(13,156) |
(4,199) |
Purchase of intangible assets |
(74) |
(81) |
|
1,792 |
(57) |
Financing activities |
|
|
Lease principal payments |
(823) |
(604) |
|
(823) |
(604) |
(Decrease) increase in cash |
(80,475) |
4,104 |
Cash, beginning of period |
102,215 |
9,955 |
Cash, end of period |
$ 21,740 |
$ 14,059 |
The accompanying notes are an integral part of these condensed interim financial statements.